ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.60
+0.41 (4.46%)
Aug 23, 2024, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Market Capitalization | 677 | 502 | 265 | 579 | 1,240 | - | |
| Market Cap Growth | 36.22% | 89.55% | -54.26% | -53.32% | - | - | |
| Enterprise Value | 401 | 285 | 84 | 302 | 1,053 | - | |
| Last Close Price | 9.60 | 9.20 | 5.89 | 14.70 | 33.85 | - | |
| PE Ratio | - | -4.70 | -2.62 | -7.09 | -10.08 | - | |
| PB Ratio | 2.15 | 2.24 | 1.19 | 2.12 | 4.28 | - | |
| P/FCF Ratio | -4.75 | -5.80 | -3.43 | -9.57 | -27.00 | - | |
| P/OCF Ratio | -4.78 | -5.86 | -3.52 | -9.72 | -27.39 | - | |
| EV/EBITDA Ratio | -1.37 | -2.60 | -0.97 | -3.87 | -21.78 | - | |
| EV/EBIT Ratio | -1.36 | -2.58 | -0.96 | -3.83 | -21.35 | - | |
| EV/FCF Ratio | -1.69 | -3.30 | -1.08 | -4.99 | -22.93 | - | |
| Debt / Equity Ratio | 0.03 | 0.05 | 0.05 | 0.05 | - | - | |
| Debt / FCF Ratio | -0.10 | -0.12 | -0.16 | -0.21 | - | - | |
| Quick Ratio | 14.66 | 10.18 | 13.40 | 15.64 | 32.61 | 16.65 | |
| Current Ratio | 15.08 | 10.39 | 13.68 | 15.87 | 32.96 | 16.81 | |
| Return on Equity (ROE) | -38.79% | -45.11% | -35.99% | -27.98% | -39.02% | -41.10% | |
| Return on Assets (ROA) | -25.20% | -27.74% | -19.87% | -16.50% | -15.69% | -25.36% | |
| Return on Capital (ROIC) | -26.41% | -29.54% | -20.86% | -17.14% | -16.33% | -27.30% | |
| Earnings Yield | -16.36% | -20.06% | -33.66% | -13.60% | -5.94% | - | |
| FCF Yield | -14.83% | -17.24% | -29.16% | -10.45% | -3.70% | - | |
| Buyback Yield / Dilution | -48.28% | -29.75% | -4.48% | -72.97% | -1055.26% | -9.53% | |
| Total Shareholder Return | -48.28% | -29.75% | -4.48% | -72.97% | -1055.26% | -9.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.